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To examine the relationship between protein disulﬁde isomerase family members within the mammalian endoplasmic
reticulum, PDI, ERp57, ERp72, and P5 were depleted with high efﬁciency in human hepatoma cells, either singly or in
combination. The impact was assessed on the oxidative folding of several well-characterized secretory proteins. We show
that PDI plays a predominant role in oxidative folding because its depletion delayed disulﬁde formation in all secretory
proteins tested. However, the phenotype was surprisingly modest suggesting that other family members are able to
compensate for PDI depletion, albeit with reduced efﬁcacy. ERp57 also exhibited broad speciﬁcity, overlapping with that
of PDI, but with preference for glycosylated substrates. Depletion of both PDI and ERp57 revealed that some substrates
require both enzymes for optimal folding and, furthermore, led to generalized protein misfolding, impaired export from the
ER, and degradation. In contrast, depletion of ERp72 or P5, either alone or in combination with PDI or ERp57 had minimal
impact, revealing a narrow substrate speciﬁcity for ERp72 and no detectable role for P5 in oxidative protein folding.
INTRODUCTION
Proteins entering the secretory pathway are initially targeted
to the endoplasmic reticulum (ER) where protein folding
and posttranslational modiﬁcations take place in a special-
ized environment. Critical among these modiﬁcations is the
formation, isomerization, and reduction of disulﬁde bonds
catalyzed by thiol oxidoreductases of the protein disulﬁde
isomerase (PDI) family. Assignment of as many as 20 pro-
teins to the mammalian PDI family is based on the presence
of at least one thioredoxin-like domain, with catalytic activ-
ity determined by the presence of a pair of cysteine residues
within a CXXC motif that is able to alternate between disul-
ﬁde and dithiol forms (Appenzeller-Herzog and Ellgaard,
2008; Hatahet et al., 2009). To act as an oxidase and form
disulﬁde bonds, the active site must itself be oxidized,
whereas reduction and isomerization events are carried out
when the active site is reduced. Although relatively few
substrates have been examined in detail, it appears that
disulﬁde isomerization is a slow process that may be rate-
limiting in the folding of certain proteins. In vitro studies on
the oxidative folding of bovine pancreatic trypsin inhibitor
revealed that partially disulﬁde-bonded intermediates be-
come kinetically trapped during folding and that isomeriza-
tion of disulﬁdes was the main process responsible for the
1000-fold enhancement in folding rate observed in the
presence of PDI (Weissman and Kim, 1993). Furthermore, in
vivo studies have shown that both the HIV-1 envelope gly-
coprotein (Land et al., 2003) and low-density lipoprotein
receptor (Jansens et al., 2002) form a number of incorrect
disulﬁde bonds early in folding and that posttranslational
isomerization events are then required for reshufﬂing and
native folding.
PDI was the ﬁrst ER thiol oxidoreductase to be character-
ized (Goldberger et al., 1964), and its oxidase and isomerase
activities have been validated in vitro (Lyles and Gilbert,
1991), in yeast (Laboissiere et al., 1995; Kulp et al., 2006), and
in mammalian systems (Bulleid and Freedman, 1988). The
structure of yeast PDI reveals a U-shaped orientation of its
four thioredoxin-like domains, termed a, b, b, and a, where
a and a denote the catalytically active domains containing
the CXXC motif and b and b are noncatalytic domains
(Kemmink et al., 1997; Tian et al., 2006). The b domain
appears to be the main site for substrate binding and for the
reported chaperone functions of PDI (Klappa et al., 1998;
Horibe et al., 2004). There is a hydrophobic surface within
the interior of the U structure that is provided by the b
domain as well as the other domains that appears well
suited for interaction with nonnative folding intermediates
(Tian et al., 2006). Indeed, direct interactions between a
hydrophobic pocket in the b domain of PDI spanning resi-
dues 240–320 and the amphipathic peptides mastoparan
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3093and somatostatin, as well as with unfolded RNase A, have
been documented recently in NMR titration studies (Den-
isov et al., 2009). On substrate oxidation, the catalytic sites of
PDI are reduced and must be reoxidized for subsequent
rounds of catalysis. This is accomplished by the FAD-bind-
ing oxidase Ero1 that donates oxidizing equivalents to PDI
in both yeast (Sevier and Kaiser, 2002) and mammals
(Mezghrani et al., 2001; Wang et al., 2009). PDI has also been
implicated in maintaining redox homeostasis as a feedback
regulator of Ero1 (Appenzeller-Herzog et al., 2008) and by
retaining Ero1 in the ER (Otsu et al., 2006). Although PDI
carries out all the functions of a thiol oxidoreductase in the
ER, many other enzymes in this family can catalyze these
reactions in vitro (Alanen et al., 2006). Consequently, there
has been great interest in determining the extent to which
PDI family members exhibit functional overlap versus
unique properties such as restricted substrate speciﬁcities.
This issue has been addressed in S. cerevisiae that pos-
sesses ﬁve PDI family members of which only PDI is essen-
tial. In most instances, the ability of individual family mem-
bers to restore viability to a PDI-deleted strain, when
overexpressed, required low level expression of one of the
other homologues. Furthermore, only PDI was capable of
supporting native folding of the carboxypeptidase Y sub-
strate (Norgaard et al., 2001). These ﬁndings indicate little
functional interchangeability within yeast PDI homologues
and underscore the predominant role of PDI in catalyzing
oxidative folding of substrates.
Similar studies in mammalian cells have been hampered
by the plethora of homologues and by the difﬁculties in
maintaining cell viability when PDI levels are constitutively
depleted (Park et al., 2006). However, transient PDI knock-
down experiments have implicated this enzyme in facilitat-
ing cholera toxin retrotranslocation from ER to cytosol
whereas the related family members ERp57 and ERp72 ei-
ther had no effect or an opposing effect, respectively (Forster
et al., 2006). Furthermore, PDI, but not ERp57, has been
shown to affect the production of infectious rotavirus parti-
cles (Maruri-Avidal et al., 2008) and the folding of human
MHC class I heavy chains (Kang et al., 2009). Additional
studies have focused on those members that most closely
resemble PDI. Of these, the best characterized is ERp57
which shares a high degree of similarity with PDI, but its
substrate-binding b domain has diverged such that it inter-
acts with the ER lectin-chaperones calnexin (Cnx) and cal-
reticulin (Crt) (Oliver et al., 1999; Kozlov et al., 2006). These
chaperones are thought to present glycoprotein substrates to
ERp57, and indeed, ERp57 has a well-established speciﬁcity
for Asn-linked glycoproteins that is abrogated when its in-
teractions with Cnx and Crt are disrupted (Zapun et al., 1998;
Jessop et al., 2009a). Nevertheless, there are several reports of
ERp57 acting directly on a few select substrates indepen-
dently of a requirement for Cnx or Crt (Peaper et al., 2005;
Schelhaas et al., 2007; Zhang et al., 2009). Studies in which
ERp57 has been depleted through RNA interference or gene
knockout have established that ERp57 is required for the
efﬁcient oxidative folding of mouse MHC class I heavy
chains (Zhang et al., 2006), inﬂuenza hemagglutinin (Solda et
al., 2006), clusterin, and 1 integrin (Jessop et al., 2007).
Another family member, ERp72, contains three catalytic
and two noncatalytic domains (Mazzarella et al., 1990) and,
although it shares high sequence similarity with ERp57, it is
not able to bind to Cnx or Crt (Kozlov et al., 2009). Limited
information is available concerning a functional relationship
between ERp72 and ERp57. ERp72 was unable to substitute
functionally for ERp57 in the oxidative folding of MHC class
I molecules (Zhang et al., 2006) but it did replace ERp57 in
mixed disulﬁde complexes with several glycoprotein sub-
strates when ERp57 was either eliminated or its recruitment
to substrates by Cnx/Crt impaired by treatment with cas-
tanospermine (Solda et al., 2006; Jessop et al., 2009b). Addi-
tionally, ERp72 has been implicated in the folding of thyro-
globulin (Menon et al., 2007) and apolipoprotein B (Linnik
and Herscovitz, 1998), but no consensus has been reached as
to how ERp72 recognizes substrates. Finally, P5 is a poorly
understood member of the PDI family with one noncatalytic
and two catalytic domains (Rupp et al., 1994). Although
found in a large multi-enzyme complex that also includes
PDI, ERp72, and BiP (Meunier et al., 2002), only recently has
it been implicated in a direct interaction with BiP, possibly
mediating its substrate selection (Jessop et al., 2009b).
Despite these ﬁndings, the question of why so many PDI
family members exist in the ER remains enigmatic. The
hypothesis of differences in substrate speciﬁcity has been
impressively investigated using substrate-trapping mutants
of PDI family members in which the second cysteine in the
CXXC active site motif is mutated to alanine. This inactivates
an escape pathway in which the second cysteine thiolate
resolves mixed disulﬁde intermediates between the ﬁrst cys-
teine and substrate (Walker and Gilbert, 1997). These studies
revealed distinct substrate proﬁles for each PDI family mem-
ber but with considerable overlap (Jessop et al., 2009a; Jessop
et al., 2009b). Most notable was a strong preference for
glycoprotein substrates by ERp57, a surprisingly wide range
of substrates for P5 and an equally surprising dearth of
identiﬁable substrates for PDI. As welcome as this informa-
tion is, the approach has a number of limitations: substrate
identiﬁcation is difﬁcult, trap mutants are overexpressed
and must compete with endogenous enzymes for substrate,
the functional role of individual family members cannot be
assessed, and, because trap mutants do not permit the CXXC
motif to become oxidized, substrates undergoing PDI mem-
ber-catalyzed oxidative folding are not detected.
To address some of these issues, we report the ﬁrst sys-
tematic knockdown of multiple PDI family members in
mammalian cells and its functional consequences on the
oxidative folding and intracellular trafﬁcking of a number of
endogenously expressed substrates, including albumin,
-fetoprotein, transferrin, 2-HS-glycoprotein, and 1-antit-
rypsin. By high efﬁciency depletion of PDI, ERp57, ERp72,
and P5, either alone or in various combinations, we assess
their relative importance in oxidative folding as well as their
functional overlap when evaluated with a common group of
substrates.
MATERIALS AND METHODS
Cell Lines and Antibodies
HepG2 cells were maintained in high glucose DMEM containing 10% fetal
bovine serum (FBS) and antibiotics. This was supplemented with either 1
g/ml puromycin (Bioshop, Toronto, ON, Canada) or 200 g/ml hygromy-
cin B (Invitrogen, Carlsbad, CA) for HepG2 cells stably expressing ERp57
shRNAmir or mutant PDI, respectively. Antibodies used in this study were as
follows: anti-PDI and -ERp72 (AssayDesigns, Plymouth Meeting, PA), anti-P5
(Afﬁnity Bioreagents, Cambridge, United Kingdom), anti-BiP (BD Biosciences,
Franklin Lakes, NJ), anti-CHOP (Thermo, Rockford, IL), anti-actin (Chemicon,
Temecula, CA), anti-albumin, -transferrin and -1-antitrypsin (Sigma, St.
Louis, MO) and anti--fetoprotein and -2-HS-glycoprotein (Abcam, Cam-
bridge, MA). Rabbit antisera directed against calnexin, calreticulin, and
ERp57 have been described previously (Danilczyk and Williams, 2001; Zhang
et al., 2006; Ireland et al., 2008). The 12CA5 anti-HA mAb was provided by Dr.
Tania Watts (University of Toronto).
Human PDI cDNA Isolation and Mutagenesis
mRNA was isolated from HepG2 cells and then cDNA was produced using
the RevertAid H Minus kit (Fermentas, Burlington, ON, Canada). Using this
as template, cDNA encoding PDI with an HA tag inserted after position D499,
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using primer pair PDI-forward: 5-ATATATAAGCTTGCGGCCGCGCCAC-
CatgCTGCGCCGC-GCTCTGCTGTGCC-3 and PDI-reverse-1: 5-AGCGT-
AATCTGGAACATCGTATGG-GTAATCGTCTTCCTCCATGTCTGGCTC-3.
These primers encode 5 NotI and HindIII sites (underlined), a Kozak se-
quence (italics), start codon (lower case) and the HA-tag (bold). This PCR
product was used as template in a second PCR with primer pair PDI-forward
and PDI-reverse-2: 5-ATATATGGATCCttaCAGTTCATCTTTCACAG-
CTTTCTGATCAGCGT-AATCTGGAACATCGTATGGGTA-3 to amplify
the complete PDI cDNA and encode the remainder of PDI following the
HA-tag (bold) including the stop codon (lower case) and a BamHI site
(underlined). The product was digested with HindIII and BamHI and ligated
into pBluescript (Stratagene, La Jolla, CA), producing pBS-PDIWT.
To generate the double mutant PDI-C56A, C400A (PDICXXA-HA), a modiﬁed
QuikChange mutagenesis protocol was performed (Zheng et al., 2004) using
plasmid pBS-PDIWT as template and the following primer pairs: C56A-forward:
5-GTGTGGCCACgcCAAaGCTtTGGCCCCTGAGTATGCCAAAG-3 and C56A-
reverse: 5-CAGGGGCCAaAGCtTTGgcGTGGCCACACCAAGGGGCATAG-3;
and C400A-forward: 5-GTGTGGTCACgcCAAACAGTTGGCTCCCATTTG-3
and C400A-reverse: 5-CACTGTTT-GgcGTGACCACACCATGGGGCATAG-3
(mutagenic nucleotides in lower case, mutated codons underlined, silent restric-
tion site in italics). The constructs encoding PDIWT-HA and PDICXXA-HA were
subcloned into plasmid pQCXIH (Clontech, Mountain View, CA) using NotI/
BamHI sites. Recombinant Moloney virus packaged with the respective pQCXIH
plasmids was used to infect HepG2 cells (Ireland et al., 2008), with stable trans-
formants selected in 200 g/ml hygromycin B.
RNA Interference
Stealth Select siRNAs (40 nm ﬁnal; Invitrogen), either speciﬁc for PDI, ERp57,
ERp72, or P5, or a negative nontargeting control, were mixed with 6 Lo f
Oligofectamine (Invitrogen) in a ﬁnal volume of 500 L of Opti-MEM me-
dium in 6-well plates. To each well, 2.5  105 HepG2 cells in 1.5 ml of DMEM
were added and, after4ha t37°C, the medium was supplemented with 1 ml
DMEM and FBS to a ﬁnal concentration of 10%. After knockdown for 3 d, the
cells were trypsinized, pooled, and resuspended for a second transfection
with fresh complexes using the same targeting siRNA. After an additional 3 d,
cells were prepared for analysis. For transfections with two different siRNAs,
the above protocol was carried out but treatment with each siRNA was
staggered by one day, extending the total time to 7 d.
For constitutive knockdown of ERp57, recombinant Moloney virus pack-
aged with pSM2c-ERp57shRNAmir (OpenBiosystems, Huntsville, AL) was
used to infect HepG2 cells as described above. Transformants were subjected
to a second infection with virus as well as clonal selection to maximize
knockdown efﬁciency. Double and triple knockdowns were carried out in this
cell line using siRNAs as described above.
Unfolded Protein Response Induction and RT-PCR
Positive controls for unfolded protein response (UPR) induction were carried
out by treating HepG2 cells with either 0.5 or 5 g/ml tunicamycin (Sigma)
dissolved in DMSO or an equivalent volume of DMSO only (control) over-
night at 37°C. Cells were split for immunoblot analysis and for RNA isolation.
Total RNA was subjected to one-step reverse transcription PCR (Qiagen,
Chatsworth, CA) using human Xbp-1 ampliﬁcation primers: 5-GGAGTTAA-
GACAGCGCTTGG-3 and 5-GAGATGTTCTGGAGGGGTGA-3.
Metabolic Radiolabeling and Immunoisolation
After RNAi, HepG2 cells (1  106) were starved for 30 min with Met-free
RPMI 1640 and radiolabeled for 3 min in 1 ml of medium containing 0.1 mCi
of [35S]Met (1000 Ci/mmol; Perkin Elmer, Boston, MA). The cells were
chased for various times in RPMI 1640 supplemented with 1 mM Met and
then incubated on ice for 3 min in 2 ml of PBS supplemented with 20 mM
N-ethylmaleimide (NEM; Sigma). Cells were then lysed at 4°C in 1 ml RIPA
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25%
Na-deoxycholate (DOC), 0.1% SDS, and protease inhibitors) containing 20
mM NEM and subjected to serial immunoisolations with 30 g anti-albumin,
anti-transferrin, anti–-fetoprotein, anti–-2-HS-glycoprotein, and anti–-1-
antitrypsin antibodies. In each case, following2ha t4°C, immune complexes
were recovered by incubation for 1 h with 30 L of protein-A agarose beads
(GE Healthcare, Little Chalront, Buckinghamshire, United Kingdom). Agar-
ose-bound immune complexes were washed four times with 50 mM Tris pH
7.4, 150 mM NaCl, 1 mM EDTA, 0.1% NP-40, 0.025% DOC, 0.01% SDS and
split for elution in SDS-PAGE sample buffer either lacking or containing 40
mM DTT. Samples were analyzed by SDS-PAGE (10% gels), detected using a
Storm phosphorimager (Molecular Dynamics; GE Healthcare), and quantiﬁed
with ImageQuant software (GE Healthcare).
For sequential immunoisolation of mixed disulﬁde complexes between
PDICXXA-HA and substrates, HepG2 cells expressing mutant PDI or the viral
vector were pulsed for 15 min with 50 Ci/plate of [35S]Met, incubated with
PBS containing 20 mM NEM, and lysed as outlined above. Immunoisolation
was carried out using anti-HA antibody and protein-A agarose with immune
complexes eluted and disrupted by incubation at 40°C for 1 h in 0.2% SDS in
PBS (pH 6.8). The eluates were adjusted to 2% NP-40, 5 mg/ml gelatin, and
50 M HA peptide (Genscript, Piscataway, NJ) in PBS (pH 6.8) before a
second round of immunoisolation with anti-substrate antibody. Immune
complexes were analyzed by reducing SDS-PAGE (10% gel) and visualized by
ﬂuorography.
RESULTS
Effective Knockdown of PDI Family Members without
Observable UPR Induction
Because attempts have failed to obtain mammalian cell lines
that constitutively express very low levels of PDI (Park et al.,
2006), a transient RNAi knockdown approach was used to
assess the functions of PDI family members in human hep-
atoma cells. For high efﬁciency knockdown, it was necessary
to carry out the knockdown over a period of 6 d with two
transfections of the targeting siRNA. Cell growth was equiv-
alent in both control and knockdown conditions after the
ﬁrst transfection, but following the second application of
siRNA a slowing of growth rate was observed in cells treated
with targeting siRNA compared with cells treated with control
siRNA (75% of control rate for PDI knockdown and 85%
for knockdown of other PDI family members). However, no
accompanying loss of cell viability or impairment of protein
translation was observed (data not shown).
Using the two-step transfection method, 95% knock-
down efﬁciency was attained for PDI, ERp57, ERp72, and P5
using either of two independent siRNAs (Figure 1A). HepG2
cells constitutively expressing shRNA targeting ERp57
(ERp57sh) also exhibited knockdown of ERp57 comparable
to that observed with siRNA. These cells facilitated experi-
ments in which both ERp57 and a second or third PDI family
member were depleted in combination. Knockdown efﬁ-
ciency also exceeded 95% in the various combination knock-
downs (Figure 1A). No off-target knockdown was observed
for other PDI family members, and in no case was compen-
satory upregulation of remaining family members observed.
We anticipated that depletion of PDI family members
might induce the UPR. Surprisingly, there was no increase
in the expression of BiP, PDI or CHOP, representing middle
and late stages of the UPR, in any of the single or multiple
knockdowns (Figure 1A) (Wu and Kaufman, 2006). Addi-
tionally, there was no alteration in the levels of Cnx or Crt.
To monitor the IRE-1 pathway directly, we tested for Xbp-1
splicing (Yoshida, 2007), and the spliced product was not
observed in any of the knockdown conditions compared
with cells treated with tunicamycin as a positive control
(Figure 1B). Similarly, there was no evidence of PERK path-
way activation as measured by phosphorylation of eIF2
(data not shown).
We further tested whether PDI-depleted cells might be
more susceptible to externally imposed ER stress. HepG2
cells were subjected to knockdown for an extended period of
ten days including an additional siRNA transfection on day
6 to maintain cellular siRNA concentration. As shown in
Figure 1C, greater than 95% knockdown of PDI was main-
tained during this period, yet remarkably there was no
evidence of UPR induction as assessed either by Xbp-1 splic-
ing or by increased BiP expression (Figure 1C, compare
lanes 1 and 4). These cells were subsequently tested for their
sensitivity to ER stress induced by tunicamycin. Control
cells exhibited Xbp-1 splicing and a 1.4-fold increase in BiP
level only at 5 g/ml tunicamycin, but in 10-d PDI-depleted
cells Xbp-1 splicing and increased BiP expression (1.5-fold)
were apparent at a 10-fold lower concentration of tunicamy-
cin. Furthermore, at 5 g/ml tunicamycin, the increase in
BiP level (1.9-fold) and extent of Xbp-1 splicing in PDI-
depleted cells exceeded those observed in control cells (Fig-
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PDI, although not exhibiting an overt UPR themselves, are
more sensitive to ER stress imposed through tunicamycin
treatment. Because the degree of Xbp-1 splicing and BiP
upregulation in control HepG2 cells was remarkably modest
after tunicamycin treatment (Figure 1C), it may be that these
professional secretory cells have higher basal levels of fold-
ing and ER-associated degradation (ERAD) machineries,
and so they do not respond as readily as other cell types to
stress conditions. Indeed, it has been reported that nearly
75% of endogenous apolipoprotein B-100 in HepG2 cells is
constitutively degraded cotranslationally (Adeli et al., 1997),
suggesting that misfolded substrates may be disposed of
without the need for an additional UPR.
The preceding data indicate that the 6-d period chosen for
PDI family member depletion is suitable to assess the func-
tions of PDI family members without confounding factors
such as compensatory upregulation of other family mem-
bers or induction of the UPR.
Identiﬁcation of PDI Substrates
Human HepG2 cells were selected for these experiments
because they express many well characterized secretory pro-
teins that possess disulﬁde bonds. Albumin (Alb), -fetopro-
tein (FP), and transferrin (TF) are attractive study subjects
since they are monomeric, contain multiple disulﬁdes, and
have molecular weights sufﬁciently low for oxidative fold-
ing to be monitored by nonreducing SDS-PAGE. Further-
more, FP and TF are glycosylated whereas Alb is not,
which permits an assessment of glycoprotein preference by
PDI family members during catalysis of oxidative folding.
To ﬁrst conﬁrm that these secretory proteins are indeed
substrates of PDI, HepG2 cells were prepared that constitu-
tively express an HA-tagged substrate-trapping mutant of
PDI (PDICXXA-HA) (Figure 2A). Mutation of the second Cys
in both PDI active sites stabilizes mixed-disulﬁde reaction
intermediates with substrates on which it is acting as a
reductase or isomerase (Walker and Gilbert, 1997). Although
our focus is on oxidative folding, it is likely that in the case
of PDI it selects substrates largely through hydrophobic
interactions regardless of the reaction catalyzed (Tian et al.,
2006). Radiolabeled cells expressing PDICXXA-HA were sub-
jected to a ﬁrst round of immunoisolation with anti-HA
mAb followed by disruption of immune complexes and a
second round of immunoisolation with Ab directed against
Figure 1. Efﬁcacy of PDI family member
knockdown and assessment of UPR. (A) PDI
family members were depleted from HepG2
cells by RNAi over a period of 6 d. Indicated
single or multiple knockdowns were carried
out transiently using two independent target-
ing siRNAs, designated (1) and (2), or in some
instances using cells constitutively expressing
shRNAmir targeting ERp57 (ERp57sh). Equiv-
alent amounts of cell lysates were immuno-
blotted for PDI family members, ER chaper-
ones, CHOP, and actin. Images shown are a
composite from various experiments, all of
which included actin as a loading control.
Exposures were adjusted to an equivalent
density of the actin control. Data are repre-
sentative of a minimum of ﬁve replicate
knockdowns. (B) After the indicated knock-
downs or overnight treatment with 5 g/ml
tunicamycin, total RNA was isolated from
HepG2 cells and analyzed for Xbp-1 splicing
by reverse-transcription PCR. Xbp-1U,u n -
spliced Xbp-1 product; Xbp-1S, spliced Xbp-1
product. (C) HepG2 cells were subjected to
PDI knockdown for 10 d. On day 9, cells were
treated overnight with the indicated concen-
trations of tunicamycin (Tm). The following
day, cell lysates were immunoblotted to de-
tect PDI, BiP, and actin. Lanes shown were
assembled from a single gel. Total RNA was
also isolated and analyzed for Xbp-1 splicing.
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and TF could all be recovered as complexes with the PDI
trap mutant, conﬁrming them as PDI substrates. Other
bands observed in complex with the PDI trap mutant were
not identiﬁed but presumably correspond to additional PDI
substrates (Figure 2B, lane 2). In addition to Alb, FP, and
TF, 2-HS-glycoprotein (2HS) was selected for study based
on high disulﬁde content and available reagents. As a neg-
ative control to detect any pleiotropic effects of PDI family
member knockdown, 1-antitrypsin (1AT) was selected be-
cause it is a glycoprotein that lacks disulﬁde bonds.
Individual Knockdown of PDI Family Members
To determine the contributions of PDI, ERp57, ERp72, and
P5 to the oxidative folding of secretory proteins, pulse-chase
experiments were carried out under control and knockdown
conditions. Free thiols were alkylated with membrane-per-
meable NEM before cell lysis to prevent air oxidation and
disulﬁde isomerization. As shown for PDI knockdown in
Figure 3A, nonreducing SDS-PAGE was used to monitor the
progression of substrate proteins from the fully reduced (R)
form of slow mobility to partially oxidized (PO) and fully
oxidized forms (O) of higher mobilities. For FP and 2HS,
the fully oxidized form was further converted to one or two
slower-mobility species (G, G1), reﬂecting processing of their
oligosaccharide chains to larger complex structures in the
Golgi. A reduction in signal was also apparent at late chase
times due to secretion, and fully oxidized species could be
recovered from the culture medium (Figure 3B). These were
included when calculating percentages of proteins oxidized or
secreted (Figure 3, B and C). In addition, the region near the top
of the gel as well as the stacking gel were monitored for
disulﬁde-linked aggregates, because previous PDI and ERp57
depletion studies involving overexpressed exogenous sub-
strates had reported signiﬁcant quantities of such aggregates
(Solda et al., 2006; Lee et al., 2010). However, we did not observe
disulﬁde-linked aggregates upon PDI family member deple-
tion, either individually or in combination, for any of our
endogenous substrates (shown only for Alb in Figures 3–6).
During the oxidative folding of Alb and FP, formation of
disulﬁde bonds was very rapid and a substantial shift in gel
mobility was seen even in the 3 min pulse period (Figure 3A,
control; compare lane P -/ DTT). Only one distinct par-
tially oxidized species was observed under control condi-
tions that slowly progressed to fully oxidized forms (species
O and G) over the course of 30–60 min. On depletion of PDI,
the impact on oxidative folding was remarkably modest for
both proteins. The initial rapid formation of the partially
oxidized species during the 3-min pulse period was un-
changed, but progression to the fully oxidized species dur-
ing the subsequent 10 min of chase was delayed (Figure 3A,
PDI lanes and Figure 3C, dashed lines). No other partially
oxidized forms were observed. By 20–30 min of chase, the
proportion of fully oxidized Alb and FP (O  G species) in
PDI-depleted cells became similar to that in control cells,
although it was noted that in the PDI-depleted cells the
conversion of the FP O species to the Golgi-processed G
species was delayed. Because nonnative protein conformers
are normally subject to quality control and retained in the
ER, we also monitored secretion rates and, in the case of
glycoproteins, ER to Golgi transport rates as an indirect
measure of folding efﬁciency. This method has been used
previously to detect incorrectly disulﬁde-bonded conform-
ers in proteins that exhibit an otherwise normal extent of
oxidation (Chakravarthi and Bulleid, 2004; Solda et al., 2006).
Both Alb and FP appeared in the culture medium at similar
rates in the absence or presence of PDI (Figure 3B). ER to
Golgi transport of FP was measured by the rate at which its
oligosaccharides were processed from an endo H-sensitive
ER form to a complex endo H–resistant form in the medial-
Golgi (Figure 3D, quantiﬁed in Figure 3E). In the absence of
PDI, ER to Golgi transport of FP was notably delayed at the
30 min chase time, consistent with the delay noted above in
the conversion of the FP O species to the G species at 30
min in Figure 3A. Because control experiments revealed no
delay in the ER to Golgi transport of nondisulﬁde-bonded
1-antitrypsin (1AT), the delay observed for FP was spe-
ciﬁc to this protein. Given that FP exhibited a similar
degree of disulﬁde formation at the 30 min chase point in the
absence or presence of PDI (Figure 3C), these data are con-
sistent with the presence of nonnative folding intermediates
that may require a disulﬁde isomerization event, delayed in
the absence of PDI, to be released from the ER quality
control machinery.
The oxidative folding of TF occurred at a slower pace than
Alb or FP, and the fully oxidized form was not detectable
until 10 min of chase under control conditions (Figure 3, A
and C). Multiple partially oxidized folding intermediates
were visible as a smear between the fully reduced and fully
oxidized forms. On depletion of PDI, the formation of the
various partially oxidized species appeared unaffected but
the rate of their subsequent conversion to the fully oxidized
species was delayed. However, by 60 min of chase, TF was
maximally oxidized in both control and PDI-depleted cells.
PDI-depletion also resulted in slower ER to Golgi transport
of TF, most apparent by 60 min of chase (Figure 3, D and E),
although no difference in its rate of secretion was detected
Figure 2. Identiﬁcation of PDI substrates. (A) Lysates of HepG2
cells stably expressing either the pQCXIH expression vector (vector)
or HA-tagged PDI carrying C56A and C400A mutations (PDICXXA-
HA) were immunoblotted with anti-HA antibody. (B) HepG2 cells
expressing either vector or PDICXXA-HA were radiolabeled with
[35S]Met for 15 min, and treated with 20 mM NEM in PBS. Cell
lysates were immunoisolated with anti-HA antibody, immune com-
plexes were disrupted and then immunoisolated a second time with
the indicated antibodies. Proteins were separated by reducing SDS-
PAGE and visualized by ﬂuorography. Alb, albumin; FP, -feto-
protein; TF, transferrin.
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clearly distinguishable fully reduced, partially oxidized, and
fully oxidized forms, but only a slight delay in oxidative
folding was observed at the 10- and 20-min chase times in
PDI-depleted cells (Figure 3, A and C). By 30 min of chase,
2HS was fully oxidized (species O, G, G1) in both control and
PDI-depleted cells. A modest delay in ER to Golgi transport
was also observed in PDI-depleted cells at 20 and 30 min of
chase (Figure 3, D and E). It is noteworthy that slower ER to
Golgi transport was manifested for both TF and 2HS at time
points when they were maximally oxidized, again suggestive
of nonnative disulﬁdes in the absence of PDI.
Overall, PDI appears to be a versatile and prominent
oxidoreductase in that its depletion affected all substrates
tested and other PDI family members could not fully com-
plement its loss. However, the phenotypes observed were
more modest than expected given the essential role of PDI in
yeast, raising the question of whether other PDI family
members are able to substitute to some degree for the func-
tions of PDI.
Figure 3. Effect of PDI knockdown on oxidative folding of secretory proteins. HepG2 cells were depleted of PDI or treated with control
siRNA for 6 d, radiolabeled with [35S]Met for 3 min, then chased with unlabeled Met for the indicated times. The medium was removed, and
then cells were treated on ice with 20 mM NEM in PBS and lysed in RIPA buffer containing 20 mM NEM. Both cell lysates and media were
immunoisolated with antisera directed against the indicated proteins. (A) Kinetics of disulﬁde formation. Immune complexes from cell
lysates were subjected to SDS-PAGE under reducing (ﬁrst lane) or nonreducing conditions and proteins were visualized and quantiﬁed by
phosphorimaging. Shown are representative gels of three independent experiments for substrates albumin (Alb), -fetoprotein (FP),
transferrin (TF), and 2-HS-glycoprotein (2HS). Reduced (R), partially oxidized (PO), oxidized (O), and Golgi (G, G1) forms of each protein
are indicated. (B) Secretion kinetics. Immune complexes recovered from media samples at the indicated chase times were analyzed by
SDS-PAGE and visualized and quantiﬁed by phosphorimaging. Histograms indicate the amount of protein observed in the medium as a
percentage of the combined intra- and extracellular signal at each chase time. Black and gray bars represent control (C) and knockdown (KD)
conditions, respectively. (C) Quantiﬁcation of gels shown in panels A and B was carried out by expressing the amount of fully oxidized
protein in lysate and media samples as a percentage of the total combined amount of reduced, partially oxidized, and oxidized forms at a
given time point. Solid lines represent control conditions; dashed lines represent knockdown conditions. (D) ER to Golgi transport kinetics.
The indicated proteins were immunoisolated and either digested or not with endo H as indicated and analyzed by reducing SDS-PAGE. Endo HS
and Endo HR represent endo H–sensitive and -resistant species, respectively. G and ER represent Golgi-processed and ER forms which could be
resolved without endo H digestion. (E) Quantiﬁcation of the gels in panel D. Histograms represent the amount of protein remaining in the ER as
a percentage of the total protein recovered from cells and medium at each time point. Black bars, control; gray bars, knockdown. Error bars
represent the average of three independent experiments  one SD, except in the case of TF which was examined in a single experiment.
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substrates for changes in oxidative folding and intracellular
transport. For Alb there was no observed difference in oxi-
dative folding in cells with or without ERp57 and no
changes in secretion efﬁciency (Figure 4, A–C). In contrast,
FP and 2HS, exhibited modest delays in oxidative folding
similar to those observed upon depletion of PDI. However,
unlike PDI depletion, there was little impact on rates of ER
to Golgi transport, suggesting that native disulﬁdes were
being formed (Figure 4, D and E). For TF, ERp57 depletion
resulted in a marked delay in oxidative folding that was
considerably more pronounced than that observed with PDI
depletion (Figure 4, A–C). This occurred through 60 min of
chase, at which time only 45% of transferrin had reached a
fully oxidized state in the absence of ERp57 compared with
85% fully oxidized transferrin in PDI-depleted cells (com-
pare Figures 3C and 4C). By 2h, almost all of TF in the cells
and medium was fully oxidized (Figure 4, A–C, TF panel).
Although secretion of TF was not signiﬁcantly delayed upon
ERp57 depletion, ER to Golgi transport was substantially
impaired (Figure 4, D and E). This was observed throughout
30–90 min of chase, reﬂecting the slower formation of disul-
ﬁde bonds. These data indicate that TF is a substrate highly
speciﬁc to ERp57 and that other family members, such as
PDI, are acting on this substrate with reduced efﬁcacy. Even
the modest phenotypes observed upon ERp57 depletion for
FP and 2HS suggest that PDI, despite being able to act on
these substrates, is not able to fully complement the loss of
ERp57 for these client proteins. The lack of impact of ERp57
depletion on the folding of Alb stands in contrast to the
other substrates. Alb is the only protein in this set that is not
glycosylated and hence is less likely to be targeted via Cnx
or Crt to ERp57 (Jessop et al., 2009a). This is in agreement
with previous work suggesting that the action of ERp57 is
largely speciﬁc for glycoproteins (Oliver et al., 1999; Solda et
al., 2006; Jessop et al., 2009a).
Individual knockdowns of ERp72 and P5 were also car-
ried out. However, there was no change in the oxidative
folding of any of the substrates tested and no changes were
observed in their rates of ER to Golgi transport or secretion
(data summarized in Table 1). Because the preceding data
indicated that the secretory proteins under study are sub-
strates for PDI and/or ERp57, it is possible that any contri-
bution of ERp72 or P5 to the oxidative folding of these
Figure 4. ERp57 depletion delays oxidative folding of glycosylated substrates. HepG2 cells were depleted of ERp57 or treated with control
siRNA and pulse-chase experiments were conducted and analyzed as described in Figure 3. (A) Kinetics of disulﬁde formation. (B) Secretion
kinetics. Black and gray bars represent control and knockdown conditions, respectively. (C) Quantiﬁcation of oxidative folding. Solid lines,
control conditions; dashed lines, knockdown conditions. (D) ER to Golgi transport kinetics. (E) Quantiﬁcation of the gels in panel D. Error
bars represent the average of three independent experiments  one SD, except in the case of TF which was examined in a single experiment.
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Alternatively, ERp72 and P5 may not act on these substrates
but are speciﬁc for other client proteins. To distinguish
between these possibilities as well as to characterize the
degree of functional overlap between PDI and ERp57, PDI
family members were depleted in combination.
Combined Knockdown of PDI Family Members
Initially, PDI and ERp57 were knocked down with high
efﬁciency (Figure 1A). As shown in Figure 5, A and B and
quantiﬁed in Figure 6A, we observed a marked decrease in
the total radioactive signal recovered from cell lysates and
medium in double-knockdown cells beyond 30 min of chase,
consistent with degradation of all substrate proteins (ex-
plored further below). Because this degradation complicated
the determination of the percentage of fully oxidized or
ER-localized forms of the substrates at later time points,
quantiﬁcations were carried out up to the 30-min time point
but not beyond (indicated by the asterisks in Figure 5, C and
E). Additionally, the amount of each substrate secreted was
quantiﬁed as a percentage of the total radioactive signal
recovered at the 10-min chase time rather than as a percent-
age of the total signal recovered at each chase time. Figure 5,
A and C shows that the oxidative folding of Alb was delayed
to the same extent as when PDI alone was depleted, sup-
porting our ﬁnding that ERp57 is not acting on this nongly-
cosylated substrate (Figure 4). For the glycoprotein sub-
strates, a range of impairments in oxidative folding was
observed. For FP, there was little change relative to PDI or
ERp57 depletion alone. For 2HS, there was a greater delay
in oxidative folding compared with that observed with ei-
ther of the single knockdowns and, in the case of TF, oxida-
tive folding was profoundly impaired. By 30 min of chase,
only 15% of TF was fully oxidized compared with 25 and
50% when either PDI or ERp57 were depleted, respectively
(compare Figures 3C, 4C, and 5C). Even after2ho fchase,
only small amounts of fully oxidized TF could be observed
(Figure 5A). Furthermore, both secretion and ER to Golgi
Figure 5. Combined knockdown of PDI and ERp57 substantially impairs protein folding. HepG2 cells constitutively depleting ERp57 by
shRNAmir were subjected to knockdown of PDI by siRNA for 6 d. HepG2 cells transfected with control siRNA were prepared in parallel.
Pulse-chase experiments were conducted and analyzed as described in Figure 3. (A) Kinetics of disulﬁde formation. (B) Secretion kinetics.
Amount secreted was quantiﬁed as a percentage of the total signal recovered at the 10 min chase time point. Black and gray bars represent
control and knockdown conditions, respectively. (C) Quantiﬁcation of oxidative folding. Solid lines, control conditions; dashed lines,
knockdown conditions. (D) ER to Golgi transport kinetics. (E) Quantiﬁcation of the gels in panel D. Error bars represent the average of three
independent experiments  one SD, except in the case of TF which was examined in a single experiment. Asterisks indicate quantiﬁcations
were not included beyond 30 min of chase due to substrate degradation.
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ure 5, B, D, and E). On comparison to the 1AT control, it
was further observed that even a secretory protein lacking
disulﬁde bonds was delayed both in its trafﬁcking from ER
to Golgi and its secretion. This suggests that combined de-
pletion of ERp57 and PDI leads to a generalized impairment
of ER function. The observed degradation of substrate pro-
teins (Figure 6A) was investigated further in the case of TF
by treating control and PDI/ERp57-depleted cells with the
proteasome inhibitor lactacystin and examining both the
subcellular distribution of TF by immunoﬂuorescence mi-
croscopy and its steady state levels by immunoblotting. As
shown in Figure 6B, ER morphology as assessed by Cnx
staining was not grossly altered upon combined PDI and
ERp57 depletion either alone or after treatment with lacta-
cystin. TF exhibited a reticular ER staining pattern in both
control and PDI/ERp57-depleted cells. However, staining
was more intense in the depleted cells consistent with ER
accumulation and the intensity increased substantially upon
inhibition of proteasomal degradation. This was conﬁrmed
by immunoblotting wherein cellular levels of TF increased
2.2-fold upon combined PDI and ERp57 depletion relative to
control cells and threefold following lactacystin treatment
(Figure 6C). These data are consistent with a substantial
degree of protein misfolding accompanying the combined
loss of PDI and ERp57 and the subsequent disposal of mis-
folded proteins by ERAD. Such efﬁcient disposal of mis-
folded proteins by HepG2 cells may explain the absence of
an observable UPR upon depletion of PDI and ERp57 (Fig-
ure 1, A and B).
Collectively, the stronger phenotypes observed in the
double versus single knockdown studies support the view
that both PDI and ERp57 are involved in the oxidative
folding of the glycoprotein substrates and that neither can
fully replace the functions of the other. Furthermore, in the
context of the mild phenotypes observed with the other
combinatorial knockdowns (see below and Table 1), these
experiments underscore the prominent role that these thiol
oxidoreductases play among the four PDI family members
examined.
We next tested whether depletion of ERp72 or P5 in
combination with PDI would yield enhanced defects in fold-
ing. The combination of PDI  P5 showed no differences for
any of the four substrates tested compared with data ob-
tained for PDI knockdown alone (Table 1). For the PDI 
ERp72 knockdown combination, oxidative folding proﬁles
were comparable to PDI-depleted cells for the three glyco-
protein substrates. In contrast, there was a more pronounced
delay in the oxidative folding of Alb compared with PDI-
depletion alone suggesting that both enzymes can act on this
substrate (compare Figure 3, A and C and Figure 7). Unlike
the PDI  ERp57 combination, these cells did not display a
generalized delay in ER to Golgi trafﬁcking or in secretion
rate; indeed, the rate of Alb secretion was the same in both
control and PDI  ERp72 knockdown cells (data not
shown). Therefore, ERp72 likely recognizes a more limited
set of substrates compared with PDI or ERp57. Its effect on
Alb was likely masked in the individual ERp72 knockdown
by the presence of PDI.
To assess whether an effect of ERp72 or P5 knockdown
could be assigned in the absence of ERp57, combination
knockdowns of ERp57  ERp72 as well as ERp57  P5 were
carried out. There was no change observed in the oxidative
folding of the four substrates beyond what had been noted
for ERp57 knockdown alone (Table 1). Because the presence
of PDI in these cells may have yet been inﬂuencing our
ability to observe the impact of these family members on
glycoprotein folding, a triple knockdown was carried out,
depleting cells of PDI, ERp57, and ERp72. Remarkably, the
cells grew and remained viable and behaved as previously
observed for the PDI  ERp57 double knockdown. Alb
oxidation was delayed in a manner similar to what had been
observed in the PDI  ERp72 combination, but there was no
additional change in the oxidative folding of the glycopro-
teins due to ERp72 depletion (Table 1). This again suggests
that ERp72 does not act on these substrates but is speciﬁc for
others such as Alb. The inability to detect any effect of P5
depletion may indicate speciﬁcity for a narrow range of
substrates, none of which were included in this study, or
that it may be involved in other processes such as substrate
reduction.
Figure 6. Misfolded transferrin is degraded by the proteasome in
PDI/ERp57-depleted cells. (A) Pulse-chase data from Figures 3–5
was analyzed for changes in the total amount of radiolabeled Alb,
FP, TF, 2HS, and 1AT recovered from the combined intracellular
and medium fractions. Total protein, as measured by densitometry,
was deﬁned as 100% at the 10 min chase time. Error bars represent
the average of three independent experiments  one SD. (B, C)
HepG2 cells were treated with control siRNA or depleted of PDI
and ERp57 for 6 d and then incubated in the absence or presence of
5 g/ml lactacystin for 5 h. Cells were either plated on Cell-Tak-
treated coverslips (BD Biosciences), ﬁxed in paraformaldehyde, and
permeabilized for confocal microscopy (B) or lysed in RIPA buffer
for Western blot analysis (C). Immunoblot or immunoﬂuorescence
was carried out using the indicated antibodies (Scale bar  10 m).
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Our current understanding of the relationships among
mammalian PDI family members comes mainly from the use
of substrate trap mutants to examine the spectrum of client
proteins acted on by individual family members (Jessop et
al., 2007; Jessop et al., 2009b). However, this approach does
not detect substrates undergoing oxidative folding nor does
it permit an assessment of the functional impact of each
family member. Some functional studies on select substrates
have been undertaken by depletion of individual family
members but comparative assessment of the impact of de-
pleting different PDI members on oxidative folding has been
very limited (Solda et al., 2006; Kang et al., 2009; Zhang et al.,
2009). The present study represents the ﬁrst systematic com-
parison of the functions of mammalian PDI, ERp57, ERp72,
and P5 in the oxidative folding of multiple endogenous
substrates.
One of our more surprising ﬁndings is that depletion of
PDI in HepG2 cells had a relatively modest impact on the
oxidative folding capacity of the ER. For all substrates
tested, oxidative folding was delayed rather than arrested,
with the half-time for acquisition of the fully oxidized state
being extended from less than twofold for the 2HS and TF
substrates to approximately eightfold for Alb and FP. A
trivial explanation is that low levels of PDI remaining after
knockdown can still catalyze substantial disulﬁde forma-
tion. However, this possibility is unlikely given that esti-
mates of PDI activity required to maintain yeast viability
range from 10 to 20% (Hatahet et al., 2009), far higher than
the trace levels detectable in our experiments. Rather, the
modest phenotypes we observe are consistent with a sub-
stantial degree of redundancy among mammalian PDI fam-
ily members, although they were not able to fully comple-
ment PDI deﬁciency. Interestingly, less redundancy is
observed in yeast where PDI is absolutely required for efﬁ-
cient oxidative folding of carboxypeptidase Y; none of the
remaining family members could support carboxypeptidase
Y folding and maturation to even 50% of the efﬁciency
observed with PDI (Norgaard et al., 2001). We also noted
that PDI depletion resulted in a delay in ER to Golgi trans-
port of FP, 2HS, and TF. This occurred after the acquisi-
tion of an apparent fully oxidized state, suggesting the pres-
ence of nonnative disulﬁdes and hence a role for PDI in
catalyzing disulﬁde isomerization. This is consistent with
the ﬁnding that the isomerase activity of yeast PDI is re-
quired for efﬁcient carboxypeptidase folding in vivo (Xiao et
al., 2004). Despite the relative subtlety of the folding defects
observed upon loss of PDI, it is noteworthy that PDI silenc-
ing affected the oxidation of all substrates examined, irre-
spective of their glycosylation status. This observation is in
agreement with the generally held view that PDI is the
predominant ER thiol oxidoreductase (Hatahet et al., 2009),
directly binding to most folding proteins via hydrophobic
interactions mediated largely through its b domain (Pirnes-
koski et al., 2004; Tian et al., 2006).
The modest delay in oxidative folding upon PDI depletion
is also surprising given that oxidizing equivalents within the
ER are thought to pass from Ero1 through PDI to substrate
protein (Sevier and Kaiser, 2008). Although controversial
(Mezghrani et al., 2001), there is mounting evidence that other
Figure 7. Effect of combined PDI and ERp72
knockdown on oxidative folding of albumin.
HepG2 cells were depleted of PDI and ERp72
by siRNA or treated with control siRNA for
6 d and then subjected to pulse-chase radio-
labeling and immunoisolation of Alb as de-
scribed for Figure 3. (A) Representative gel of
Alb oxidation from three independent knock-
down experiments. (B) Quantiﬁcation of gel
shown in panel A. Solid lines, control condi-
tions; dashed lines, knockdown conditions.
Error bars represent the average of three in-
dependent experiments  one SD.
Table 1. Summary of oxidative folding defects accompanying single and combined PDI family member knockdown
Substrate MW (kDa) Glycosylation sites (N-linked) PDI ERp57 ERp72 P5
Albumin 66 0    
-Fetoprotein 66 1    
Transferrin 77 2    
2-HS glycoprotein 44 2  
1-Antitrypsin 52 3  
Substrate ERp57/PDI ERp72/PDI PDI/ERp57/ERp72 ERp57/ERp72 ERp57/P5 PDI/P5
Albumin      
-Fetoprotein      
Transferrin      
2-HS glycoprotein      
1-Antitrypsin    
The degree of delay in formation of the fully oxidized protein substrate and/or its ER to Golgi trafﬁcking rate in response to the indicated
individual or combined PDI family member knockdowns is scored from , signifying no effect, to , signifying a profound delay.
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mixed disulﬁdes with Ero1 and hence may accept oxidizing
equivalents in a similar manner (Jessop et al., 2009b). Alterna-
tively, because more than half of ER-localized glutathione has
been shown to be in the form of mixed disulﬁdes with protein
(Bass et al., 2004), this may serve as an alternative source of
oxidative equivalents in the absence of PDI.
Our studies suggest that ERp57 is a leading candidate
among PDI family members for activities that partially com-
plement PDI deﬁciency. ERp57 had the broadest substrate
speciﬁcity of the remaining PDI family members examined
in this study, contributing to the efﬁcient oxidative folding of
FP, 2HS, and TF but not of Alb. Furthermore, when ERp57
was depleted in combination with PDI, a greater impairment
in oxidative folding rates was observed for both TF and
2HS compared with either single knockdown alone and
slower export of all substrates from the ER was apparent
along with evidence of misfolding and disposal by ERAD.
Such extensive effects on protein folding and trafﬁcking
were not observed when either ERp72 or P5 was depleted in
combination with PDI, although a greater delay in the oxi-
dation of Alb was noted with combined PDI and ERp72
knockdown. These ﬁndings indicate overlapping substrate
speciﬁcities for PDI and ERp57 as well as illustrating that
both enzymes are required for the efﬁcient folding of certain
substrates, most notably TF. The generalized impairment of
protein export from the ER and disposal by ERAD upon
depletion of PDI and ERp57, but not with either enzyme
individually, suggests that both enzymes are required for
the folding of many other substrates as well. Our ﬁndings
indicate that, of the four PDI family members examined, PDI
and ERp57 contribute most substantially to oxidative pro-
tein folding within the ER. It will be of considerable interest
in the future to test the generality of this observation with an
expanded set of glycosylated and nonglycosylated sub-
strates as well as other PDI family members.
Why might an individual substrate require the activities
of both PDI and ERp57 during oxidative folding? One pos-
sibility is that individual substrate thiols exhibit substantial
variation in redox potential that require different PDI family
members for thiol-disulﬁde exchange reactions. However,
both PDI and ERp57 possess similar reduction potentials
that are substantially more oxidizing than those of substrate
thiols (reviewed in (Hatahet et al., 2009), rendering such a
requirement unlikely. Another possibility is that one en-
zyme acts primarily to catalyze disulﬁde formation whereas
the other is more involved in isomerization reactions. How-
ever, current evidence supports the ability of PDI and ERp57
to catalyze both types of reactions in vivo (Xiao et al., 2004
and see below) and further work would be required to
determine whether this varies from one substrate to another.
Perhaps a more likely possibility is that PDI and ERp57
recognize distinct substrate conformers during the folding
process. This may occur either through direct interaction
with hydrophobic patches on the substrate in the case of PDI
or indirectly through association with different chaperones.
As discussed below, ERp57 is thought to be recruited to
folding glycoproteins primarily through its association with
Cnx and Crt which recognize nonnative folding intermedi-
ates by virtue of a lectin site speciﬁc for monoglucosylated
oligosaccharides as well as through a hydrophobic polypep-
tide binding site (Williams, 2006). PDI has also been detected
in a large complex that contains BiP and Grp94, both of
which may inﬂuence PDI-substrate interactions (Meunier et
al., 2002). Such distinct modes of substrate recognition may
dictate the utilization of PDI or ERp57 at different stages of
the substrate folding pathway.
Previous studies using substrate-trapping mutants of
ERp57 (Jessop et al., 2007) or that interfered with the forma-
tion of ERp57-Cnx/Crt (Jessop et al., 2009a) or Cnx/Crt-
glycoprotein complexes (Oliver et al., 1997; Zapun et al.,
1998; Solda et al., 2006) have concluded that ERp57 has
glycoprotein speciﬁcity mediated through its association
with these lectin-chaperones. Our ﬁnding that Alb, the only
nonglycosylated substrate examined in this study, was con-
spicuously excluded from those substrates affected by the
loss of ERp57 is in good agreement with this view. Interest-
ingly, the impact of ERp57 depletion varied among the
glycoproteins examined. Whereas the effect was mild for
FP and 2HS, the impact on TF was substantial. Molinari
and coworkers recently examined the impact of ERp57 de-
pletion on different glycoproteins and found that the sever-
ity of the defect in oxidative folding correlated with the
dependency of the individual glycoprotein on the Cnx/Crt
chaperone system for folding (Solda et al., 2006). Although
the dependence on Cnx and Crt of the various secretory
glycoproteins in the present study has not been rigorously
examined, TF has been established as an obligate client of
these chaperones (Wada et al., 1997), consistent with the
strong impairment we observe upon ERp57 depletion. It is
noteworthy that delays in oxidative folding were even de-
tectable for FP, 2HS, and TF upon ERp57 depletion, given
that all three glycoproteins were demonstrated to be sub-
strates for PDI and that PDI was fully present when ERp57
was depleted. Recent studies from Jessop and coworkers
have shed light on this issue (Jessop et al., 2009a). They specu-
lated that entry of glycoproteins into the Cnx/Crt cycle might
impede access of other PDI family members, even when ERp57
was depleted. Consistent with this view, they showed that the
impaired oxidative folding of inﬂuenza HA observed upon
ERp57 depletion could be largely bypassed if HA was pre-
vented from associating with these chaperones.
There is some controversy as to whether ERp57 functions
primarily as an isomerase or oxidase during protein folding.
Previous studies by Jessop and coworkers, in which the
disulﬁde content of HA was assessed through chemical al-
kylation, revealed that the HA produced in ERp57-deﬁcient
cells was fully oxidized but contained nonnative disulﬁdes
(Jessop et al., 2009a). This led to the conclusion that ERp57
functions primarily as an isomerase. Our current ﬁndings, as
well as previous work showing that ERp57 deﬁciency slows
the formation of fully oxidized class I heavy chains by as
much as 10-fold (Zhang et al., 2006), point to a role for ERp57
in catalyzing disulﬁde formation but do not preclude the
possibility of an additional role in isomerization. Future
experiments using the chemical alkylation approach on se-
cretory proteins in ERp57-depleted HepG2 cells will help to
clarify this issue.
ERp72 is expected to possess a different substrate speci-
ﬁcity compared with PDI or ERp57. The crystal structure of
the ERp72 bb domain fragment revealed that it lacks the
hydrophobic face that is thought to mediate PDI interactions
with nonnative substrates and, on the opposite face, lacks
the positively charged patch that mediates ERp57 binding to
Cnx and Crt (Kozlov et al., 2009). Consistent with a limited
substrate speciﬁcity, a substrate trap mutant of ERp72 failed
to stabilize a signiﬁcant level of mixed disulﬁde complexes
with substrates (Jessop et al., 2009b). Thus, our inability to
detect any impact of ERp72 depletion is perhaps not sur-
prising. Only when PDI was depleted in combination with
ERp72 was a role for ERp72 revealed in the oxidative folding
of Alb, a role previously masked by PDI in the single knock-
down experiments. The lack of effect of this double knock-
down on the three glycoprotein substrates further under-
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noted that when ERp57 is depleted (Solda et al., 2006) or the
binding of Cnx or Crt to substrates is impeded through
treatment with castanospermine (Jessop et al., 2009b) several
glycoprotein substrates of ERp57 can shift to an association
with ERp72, suggesting overlapping substrate speciﬁcities.
However, we were unable to detect any involvement of
ERp72 in the oxidative folding of FP, 2HS, or TF when
ERp57 was depleted along with ERp72 or even in triple
knockdowns lacking PDI, ERp57, and ERp72. It is possible
that the engagement of these glycoproteins within the Cnx/
Crt cycle precludes interactions with ERp72 or that ERp72
simply has a narrow substrate range not sampled in the
present study.
Finally, we did not observe any impact on oxidative fold-
ing of depleting P5 alone or in combination with other PDI
family members. These data suggest either a minor role for
P5 or one speciﬁc for substrates not included in this study.
P5 has previously been reported to be part of a multi-
enzyme complex containing several ER chaperones includ-
ing BiP (Meunier et al., 2002). In the substrate-trapping study
by Jessop et al. (2009b), the authors conﬁrmed a noncovalent
interaction between P5 and BiP and reported mixed disul-
ﬁde complexes between P5 and a broad range of substrates
tested, although such complexes could only be observed
when substrates were selectively translated in a semiperme-
abilized cell system. The authors speculated that in a manner
analogous to ERp57 and Cnx/Crt, P5 is targeted to sub-
strates via its interaction with BiP. Given that BiP interacts
with many newly synthesized proteins in the ER including
those in hepatoma cells (Molinari and Helenius, 2000;
Schmidt and Perlmutter, 2005), the discrepancy between our
respective ﬁndings may reﬂect differences in the methods
used or may indicate that P5, although reported to have
oxidase activity in vitro (Lappi et al., 2004), may act predom-
inantly as a reductase to remove disulﬁde bonds in mis-
folded proteins targeted to BiP and degraded by ERAD
(Jessop et al., 2009b).
The existence of a multi-enzyme complex containing PDI,
ERp72, P5, BiP, and Grp94, but lacking Cnx, Crt, and ERp57,
has led to the suggestion that the folding of various proteins
may be segregated either spatially or temporally between
different chaperone networks (Meunier et al., 2002) and that
this may partially explain differences in PDI family member
substrate speciﬁcity (Hatahet et al., 2009; Jessop et al., 2009b).
Our data highlighting the apparent functional overlap of
PDI and ERp72 in Alb oxidation as well as the lack of
substrate sharing for ERp57 and ERp72 are in good agree-
ment with such physical separation of function. However,
our observation that both PDI and ERp57 are involved in the
oxidative folding of most substrates tested is consistent with
a more homogenous distribution of PDI family members in
the ER. We also do not observe any impact of combined
depletion of PDI and P5, which might have been expected if
substrate selection was based on physical proximity of the
oxidoreductases within a chaperone complex.
In summary, using a functional approach we have begun
to deﬁne the relative roles of different PDI family members
in oxidative protein folding within the ER. Although reveal-
ing in terms of delineating the predominant roles of PDI and
ERp57 and the lesser impact of ERp72 and P5, it is notewor-
thy that disulﬁde formation still occurred even in the context
of triple depletion conditions. An extension of this approach
to other members of the PDI family should prove informa-
tive in revealing the sources of additional oxidase activities.
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